7 assets in Cerebral Palsy

Therapeutic assets addressing Cerebral Palsy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ropivacaine Cerebral Palsy	University of California, Los Angeles	P4	BB (70)
Lidocaine Cerebral Palsy	University of California, Los Angeles	P4	BB (65)
Marcaine Cerebral Palsy	University of California, Los Angeles	P4	BB (65)
Botulinum B Toxin Cerebral Palsy	Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC	P2/3	CCC (54)
Mtr-601 Cerebral Palsy	Motric Bio	P1	CC (46)
Gip Cerebral Palsy	University of Copenhagen	N/A	D (30)
Glucagon-Like Peptide Ii Cerebral Palsy	University of Copenhagen	N/A	D (30)